Curis Lifesciences Ltd
NSE: CURIS BSE: 94348
₹99.90
(7.48%)
Fri, 03 Apr 2026, 05:42 am
Market Cap743.77M
PE Ratio0
Dividend0
Health Technology
Pharmaceuticals: Major
24.5KCompany History
2010
- The Company was originally formed and registered as a Partnership Firm under the Partnership Act.
2011
- The business started as a Partnership Firm with two Partners in the name of M/s Loreto Pharmaceutical.
2016
- The Partnership Firm was converted into a Private Company and received a certificate of incorporation on March 23, 2016.
2018
- The Company received FDA License for manufacturing Pharma products.
2019
- The Company availed Kenya PPC board approval and approval from Ministry of Health - Republic of Yemen, State Good Manufacturing Practices and GLP licence from Local FDA.
2020
- The Company received WHO GMP certificate.
2021
- The Company received FDA Approval from Philippines.
2022
- The Company renewed its WHO Certificates and received Nigeria NAFDAC Approval.
2023
- The Company retained its FDA License for manufacturing Pharma products.
2024
- The Company's status was changed to public limited and a fresh certificate of incorporation was issued on August 9, 2024.
- The name of the Company was changed from Curis Lifesciences Private Limited to Curis Lifesciences Limited via Special Resolution dated May 6, 2024.
2025
- The Company was converted from Private Limited to Public Limited.
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Calculators
Popular Calculators
Group Stocks
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800